Lannett Co. Inc.
9000 State Road
Philadelphia,
PA 19136
United States - Map
Phone: 215-333-9000
Fax: 215-333-9004
Web Site: http://www.lannett.com
| Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. Its products portfolio primarily includes Acetazolamide tablets for glaucoma; Baclofen tablets for muscle relaxation; Bethanechol Chloride tablets for urinary retention; Butalbital, Aspirin, Caffeine with Codeine Phosphate capsules to treat migraine headache; Clindamycin HCl capsules, Doxycycline tablets, Doxycycline Hyclate tablets used as antibiotics; Danazol capsules for endometriosis; Dicyclomine tablets/capsules for irritable bowels; Digoxin tablets to treat congestive heart failure; and Diphenoxylate with Atropine Sulfate tablets for Diarrhea. The company also offers Hydromorphone HCl tablets, Morphine Sulfate oral solution, and Oxycodone HCl oral solution for pain management; Levothyroxine Sodium tablets to treat thyroid deficiency; Methyltestoterone/Esterified Estrogens tablets used in hormone replacement; Phentermine HCl tablets/capsules for weight loss; Pilocarpine HCl tablets to treat dryness of the mouth; Primidone tablets for epilepsy; Probenecid tablets for gout; Sulfamethoxazole with Trimethoprim used as antibacterial; Terbutaline Sulfate tablets for bronchospasms; and Unithroid tablets to treat thyroid deficiency. Lannett Company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, and health maintenance organizations. It has supply and development agreements with Olive Healthcare of India; Orion Pharma of Finland; Azad Pharma AG of Switzerland; Unichem, Inc. of India; Wintac Limited of India; Pharmaseed in Israel; and Banner Pharmacaps and Catalent of the United States. The company was founded in 1942 and is based in Philadelphia, Pennsylvania. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Arthur P. Bedrosian J.D., 64
Chief Exec. Officer, Pres, Director, Member of Chairmans Committee and Member of Strategic Planning Committee |
N/A
| N/A | Mr. Kevin Smith , 49
VP of Sales and Marketing |
N/A
| N/A | Mr. William Schreck , 59
VP of Logistics |
N/A
| N/A | Mr. Keith R. Ruck CPA,
Interim Chief Financial Officer and Corp. Controller |
N/A
| N/A | Mr. Ernest Sabo , 61
Chief Compliance Officer and VP of Regulatory Affairs |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.45% Nasdaq 0.00%
Profile
